🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
IRD
$IRD
🔒 US EquitiesOpus Genetics Inc
AVG HISTORICAL GAP
-0.92%
MAX GAP RECORD
-4.55%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $IRD
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$IRD
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 11, 2026 Earnings Release 2026-11-11 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN) |
-1.06%
|
| May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN) |
-1.76%
|
| Mar 10, 2026 Earnings Release 2026-03-10 (BEFORE OPEN) |
+0.00%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN) |
-2.54%
|
| Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE) |
-4.55%
|
| Mar 31, 2025 Earnings Release 2025-03-31 (BEFORE OPEN) |
-3.96%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN) |
-4.27%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.4%
Bullish Gaps (3)
Bearish Gaps (7)
Neutral / Flat (3)
📖 Intelligence Summary
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗